Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.13% advanced 1.09% to $181.40 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.05% rising 0.15% to 31,928.62 and the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.06% falling 0.81% to 3,941.48. This was the stock's third consecutive day of gains. Johnson & Johnson closed $5.29 below its 52-week high ($186.69), which the company reached on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +1.62% rose 4.28% to $348.92, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.37% rose 0.86% to $94.64, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.23% rose 1.00% to $53.41. Trading volume (6.4 M) remained 1.3 million below its 50-day average volume of 7.7 M.